Response's Rapid Analyte Measurement Platform (RAMP) nears market with Canadian help:
This article was originally published in Clinica
Executive Summary
Response Biomedical has obtained a Can$350,000 ($252,000) Canadian government grant to finish developing its Rapid Analyte Measurement Platform technology. RAMP will diagnose infectious diseases, coagulation, therapeutic drug monitoring, cardiac markers and diabetes monitoring.